Life Sciences

Oct 16, 2026

Study Tests Smartphone AI for Children's Lung Sounds

Researchers developed a deep learning framework that adapts electronic stethoscope data to detect abnormal lung sounds in smartphone recordings.

Oct 16, 2026

Manhattan Physician Invests in RunPractice

Functional medicine physician Dr. Ruth Johnson invested in RunPractice and uses its practice management system at her Midtown Manhattan clinic.

Oct 16, 2026

Attilio appoints Buck Institute CEO Eric Verdin as cochairman

Longevity platform Attilio appoints Buck Institute President and CEO Eric Verdin as cochairman to guide its scientific direction and member assessments.

Oct 16, 2026

Aignostics launches HETA Clinical for pathology workflows

HETA Clinical includes four AI products that assess slide quality, tumor presence, mitotic counts and tumor cellularity in whole slide H&E images.

Oct 16, 2026

Specialty1 Partners Invests in AI for Dental Practice Operations

Specialty1 Partners is investing in AI tools for clinical documentation, patient communication, insurance administration and business operations across its dental practice network.

Oct 15, 2026

Study Tracks 270 Million Clinical AI Queries on OpenEvidence

Researchers analyzed how 950,000 US clinicians used OpenEvidence from January 2024 to June 2026. Most queries concerned clinical decisions, particularly treatment and patient management.

Oct 15, 2026

UK Medicines Regulator Plans AI Safety Tools by 2030

The MHRA plans to use AI to detect medicine safety signals earlier, improve clinical trial applications and clarify rules for AI medical products.

Oct 15, 2026

Reveleer names Jean-Luc Neptune chief medical officer

Jean Luc Neptune will lead clinical strategy across Reveleer's risk adjustment, quality and member management programs, which serve 12 million covered lives.

Oct 15, 2026

Tucuvi Joins Microsoft Pegasus Program

Tucuvi joins the Microsoft for Startups Pegasus Program to expand access to its clinical voice AI platform across health systems.

Oct 15, 2026

Zealand Pharma signs AI obesity drug deal worth up to $1.2 billion

Zealand Pharma will use Generate:Biomedicines' generative AI platform to develop protein treatments for obesity and metabolic diseases under a deal worth up to $1.2 billion.

Oct 15, 2026

Waterdrop Says AI Cut Complex Underwriting Time by 80% in 2025

Waterdrop's 2025 ESG report says its KEYI.AI underwriting system reduced processing time for complex health insurance cases by 80% and achieved 99.8% accuracy.

Oct 15, 2026

Sunbound Acquires Richter and Raises $24 Million

Sunbound acquired Richter Healthcare Consultants and closed a $24 million Series A round led by TTV Capital. The deal adds revenue cycle, accounting and consulting services for senior care operators to Sunbound's software platform.

Oct 15, 2026

SciBase Secures First US Insurance Coverage for Nevisense

SciBase secured its first medical policy from a private US insurer covering the use of Nevisense to assess certain suspicious skin lesions.

Oct 15, 2026

SimBioSys Gets FDA Clearance for AI Breast Cancer Recurrence Tool

TumorSight Risk analyzes breast MRI, pathology and clinical data to estimate recurrence risk at five and ten years for certain patients with early stage breast cancer.

Oct 15, 2026

HIMSS27 Opens Registration for 2027 Chicago Health IT Conference

HIMSS27 will take place April 5 to 8, 2027, in Chicago, with more than 600 education sessions and over 900 exhibitors.

Oct 15, 2026

wisepatientAI Launches AI Search for Medical Records

wisepatientAI now lets patients ask questions about their medical history and receive answers based on records collected from multiple providers.

Oct 14, 2026

Colossal Unveils GenoMorph AI Platform for Dodo Genome Editing

GenoMorph identified about 2,300 regulatory DNA candidates associated with bird beak size and shape, providing targets for testing in the dodo restoration program.

Oct 14, 2026

Taiwanese Health Technology Groups Test US Market in Dallas

Ten Taiwanese hospitals and health technology companies presented clinical AI, remote monitoring and rehabilitation systems at Taiwan Expo USA 2026 while seeking US validation, regulatory clearance and commercial partners.

Oct 14, 2026

Likang to Present AI Cancer Immunotherapy Platform in Abu Dhabi

Likang Life Sciences will present its AI based neoantigen discovery platform at the Abu Dhabi Future Health Summit 2026, held October 20 to 22.

Oct 14, 2026

INmune Bio and QCi Apply Quantum Computing to XPro Research

INmune Bio and Quantum Computing Inc. will use quantum optimization, AI and data analytics to identify potential disease indications and biomarkers for the investigational treatment XPro.